Key Takeaways
- AXT revealed plans for a public equity sale priced at $64.25 per share, targeting up to $632.5 million with full underwriter allocation
- Shares declined approximately 12% during Tuesday’s premarket session after the offering disclosure
- First-quarter revenue projected between $26M and $28M versus $19.4M year-over-year, though a net loss of $1.6M to $2.6M is anticipated
- Capital raised will support expansion initiatives at Beijing Tongmei unit focused on indium phosphide substrate manufacturing
- The pullback impacts an extraordinary 5,867% climb the stock achieved during the trailing twelve months
AXT Inc. (AXTI) has emerged as one of Wall Street’s most explosive success stories throughout the past year. An astronomical 5,867% surge over twelve months represents performance rarely witnessed in equity markets. However, Tuesday delivered a dose of volatility for the compound semiconductor specialist, with shares retreating approximately 12% in premarket activity following disclosure of an equity offering.
Premarket quotes showed the stock changing hands near $69.43, marking a retreat from the previous session’s close that had valued AXT’s equity at $4.38 billion.
Northland Securities is managing the transaction, which carries a price of $64.25 per share. The company intends to issue 8,560,311 common shares, while granting underwriters a 30-day over-allotment provision for an additional 1,284,046 shares. Initial gross proceeds are projected at approximately $550 million, potentially reaching roughly $632.5 million should underwriters exercise their full allocation. Closing is scheduled for April 22.
Management indicated the capital will predominantly fund operations at Beijing Tongmei Xtal Technology, its subsidiary that manufactures indium phosphide substrates for global distribution. Remaining funds will support research and development efforts, operational liquidity, and broader corporate initiatives.
The company’s executive leadership team and board members have committed to a 60-day lock-up period on their equity holdings effective from the prospectus supplement date.
The Strategic Importance of Indium Phosphide
Indium phosphide substrates serve as critical components in optical networking hardware deployed throughout data center environments. Market demand has accelerated dramatically as artificial intelligence infrastructure expansion drives requirements for ultra-high-speed data transmission capabilities. This technological tailwind fueled AXT’s remarkable appreciation throughout the previous year.
The enterprise also produces gallium arsenide and germanium substrates, addressing diverse applications spanning 5G telecommunications, LED illumination, laser systems, sensor technology, and satellite-based solar arrays. Manufacturing operations are concentrated in China, where the company maintains three production plants and holds minority ownership positions in ten raw material providers.
Notwithstanding the dramatic stock appreciation, AXT’s financial statements reveal an organization still progressing toward sustainable profitability. Management projects first-quarter revenue spanning $26 million to $28 million, representing growth from $19.4 million recorded in the corresponding period last year. Nevertheless, the company anticipates posting a net loss ranging from $1.6 million to $2.6 million during the quarter.
Valuation Metrics Draw Attention
Based on Monday’s closing price, AXT commanded a forward price-to-earnings multiple approximating 535 times. Such elevated valuations require flawless operational delivery. Any indication of decelerating growth momentum or persistent losses can trigger swift market reactions.
The most current Wall Street coverage assigns the stock a Buy recommendation accompanied by a $90 price objective.
The offering details emerged late Monday evening, prompting the sharp premarket response when Tuesday’s session opened.





